Pregnancy-associated plasma protein-A predicts survival in end-stage renal disease—Confounding and modifying effects of cardiovascular disease, body composition and inflammation
Nephrology Dialysis Transplantation Jun 06, 2018
Nilsson E, et al. - Authors gauged the relationships of pregnancy-associated plasma protein-A (PAPP-A), measured at dialysis initiation, with cardiovascular disease (CVD), CVD risk factors and mortality in incident dialysis patients, and assessed whether body composition and inflammation modulated these relationships. Findings suggested an association of higher PAPP-A levels in incident dialysis patients with worse survival after adjustment for established cardiovascular risk factors and body composition indices, but not clearly so when adjusted for high-sensitivity C-reactive protein (hsCRP). Potential effect modifiers for the observed moderate association of PAPP-A with survival were inflammation, body composition (FTI) and DM.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries